Veletri and Device occlusion - a phase IV clinical study of FDA data

Summary:

Device occlusion is reported as a side effect among people who take Veletri (epoprostenol sodium), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Adcirca, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Device occlusion when taking Veletri. It is created by eHealthMe based on reports of 14,192 people who have side effects when taking Veletri from the FDA, and is updated regularly.

What is Veletri?

Veletri has active ingredients of epoprostenol sodium. eHealthMe is studying from 14,196 Veletri users. Check the latest studies of Veletri.

What is Device occlusion?

Device occlusion is found to be associated with 591 drugs and 514 conditions by eHealthMe. Check the latest studies of Device occlusion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

14,192 people reported to have side effects when taking Veletri.
Among them, 531 people (3.74%) have Device occlusion.

Among these 531 people:

* Approximation only. Some reports may have incomplete information.

Do you take Veletri and have Device occlusion?

- Check whether Device occlusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Veletri:

Veletri (14,196 reports)

Device occlusion treatments and more:

Device occlusion (13,307 reports)

How severe was Device occlusion and when was it recovered:

Device occlusion in Veletri

Expand to all the drugs that have ingredients of epoprostenol sodium:

Device occlusion and drugs with ingredients of epoprostenol sodium (856 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Veletri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Device occlusion:

Device occlusion (591 drugs)

Browse all the conditions that are associated with Device occlusion:

Device occlusion (514 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on epoprostenol sodium (the active ingredients of Veletri) and Veletri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.